Equillium EQ
NASDAQ EQ
$2.21 -0.01 (-0.45%)
At close: Sep 4, 2026 · 4:00 PM EDT

Equillium (EQ) Accumulated Depreciation (2017 - 2025)

Equillium (EQ) posted quarterly Accumulated Depreciation of $562000.0 for Q4 2025, up 12.63% year-over-year from $499000.0 in Q4 2024, and up 12.63% quarter-over-quarter from $499000.0 in Q4 2024.

Analysis

Equillium (EQ) Accumulated Depreciation (2017 - 2025) Analysis & Trends

Equillium (EQ) has reported Accumulated Depreciation for 9 consecutive years, with $562000.0 the latest figure, recorded in Q4 2025.

  • In Q4 2025, Accumulated Depreciation rose 12.63% year-over-year to $562000.0; the TTM figure through Dec 2025 stood at $562000.0 (up 12.63% YoY), while the FY2025 annual figure was $562000.0, up 12.63% from the prior year.
  • Accumulated Depreciation climbed to $562000.0 in Q4 2025 per EQ's latest filing, from $499000.0 in the prior quarter.
  • Across five years, Accumulated Depreciation topped out at $562000.0 in Q4 2025 and bottomed at $147000.0 in Q4 2021.
  • Historically, Accumulated Depreciation has averaged $364200.0 across 5 years, with a median of $364000.0 in 2023.
  • Annual changes were most pronounced in 2021 — Accumulated Depreciation jumped 98.65% — and 2025, when it increased 12.63%.
  • Equillium's Accumulated Depreciation stood at $147000.0 in 2021, then surged by 69.39% to $249000.0 in 2022, then soared by 46.18% to $364000.0 in 2023, then surged by 37.09% to $499000.0 in 2024, then advanced by 12.63% to $562000.0 in 2025.
  • Business Quant data shows EQ's Accumulated Depreciation at $562000.0 in Q4 2025, $499000.0 in Q4 2024, and $364000.0 in Q4 2023.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn
5 Revolution Medicines 44.33 Bn 44.33 Bn -
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn
8 Royalty Pharma 28.45 Bn 27.61 Bn -
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn
10 Equillium 249.33 Mn 249.33 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 562,000.00
Dec 31, 2024 499,000.00
Dec 31, 2023 364,000.00
Dec 31, 2022 249,000.00
Dec 31, 2021 147,000.00
Dec 31, 2020 74,000.00
Dec 31, 2019 29,000.00
Dec 31, 2018 6,000.00
Dec 31, 2017 122.00